# A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

> **NCT01350947** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 11 (actual)

## Conditions studied

- Chronic Myelomonocytic Leukemia

## Interventions

- **DRUG:** 5-Azacitidine

## Key facts

- **NCT ID:** NCT01350947
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01350947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01350947, "A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT01350947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*